Response Genetics, Inc
RGDXQ · OTC
12/31/2015 | 12/31/2014 | 12/31/2013 | 12/31/2012 | |
|---|---|---|---|---|
| Market Cap | $0 | $12 | $39 | $37 |
| - Cash | $19 | $2 | $8 | $9 |
| + Debt | $6 | $10 | $1 | $1 |
| Enterprise Value | -$13 | $20 | $32 | $29 |
| Revenue | $18 | $17 | $20 | $19 |
| % Growth | 7.9% | -15.6% | 5.7% | – |
| Gross Profit | $4 | $7 | $9 | $8 |
| % Margin | 21.9% | 40.1% | 47.2% | 44.4% |
| EBITDA | -$20 | -$13 | -$8 | -$7 |
| % Margin | -109% | -77.8% | -40.1% | -38.4% |
| Net Income | -$20 | -$14 | -$7 | -$7 |
| % Margin | -111.9% | -81% | -37.8% | -39.3% |
| EPS Diluted | -0.52 | -0.35 | -0.22 | -0.28 |
| % Growth | -48.6% | -59.1% | 21.4% | – |
| Operating Cash Flow | -$14 | -$14 | -$6 | -$8 |
| Capital Expenditures | -$1 | -$0 | -$1 | -$1 |
| Free Cash Flow | -$15 | -$14 | -$7 | -$9 |